XML 37 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders Equity and StockBased Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Stockholders Equity and StockBased Compensation  
Schedule Of stock option

 

 

Number of

Options

 

 

Weighted Average Exercise Price

 

 

Weighted-Average

Remaining

Contractual

Term (Years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding, December 31, 2024

 

 

464,940

 

 

$16.24

 

 

 

3.07

 

 

$184,818

 

Granted

 

 

12,418

 

 

 

10.33

 

 

 

 

 

 

 

 

Exercised

 

 

(195,855 )

 

 

6.35

 

 

 

 

 

 

 

1,834,474

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

(17,873 )

 

 

75.60

 

 

 

 

 

 

 

 

Outstanding, September 30, 2025

 

 

263,630

 

 

$19.28

 

 

 

2.35

 

 

 

2,045,064

 

Vested and expected to vest, end of the period

 

 

263,630

 

 

$19.28

 

 

 

2.35

 

 

 

2,045,064

 

Options exercisable, end of the period

 

 

250,547

 

 

$20.04

 

 

 

2.01

 

 

$1,829,575

 

Schedule Of Share-based Compensation, Stock Options, Activity

 

 

Nine Months Ended

 

 

 

September 30,

 

 

 

2025

 

 

2024

 

Expected volatility

 

109.24% - 117.44%

 

 

75.36% - 92.89%

 

Risk free interest rate

 

3.80% - 3.95%

 

 

3.76% - 4.54%

 

Dividend yield rate

 

 

 

 

 

 

Expected life

 

2-6 years

 

 

2-6 years

 

Closing price per share - common stock

 

$9.42 - $15.13

 

 

$2.49 - $2.62

 

Schedule Of outstanding RSA

 

 

Number of

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

 

 

Aggregate

Fair

Value

 

Outstanding, December 31, 2024

 

 

781,864

 

 

$5.19

 

 

$3,698,217

 

Awards granted (including performance-based RSAs of 1,125,000 shares)

 

 

1,467,940

 

 

 

13.50

 

 

 

19,821,822

 

Awards vested

 

 

(136,768 )

 

 

6.10

 

 

 

1,346,731

 

Awards forfeited

 

 

 

 

 

 

 

 

 

Outstanding, September 30, 2025

 

 

2,113,036

 

 

$10.91

 

 

$44,817,494

 

Schedule of stock based compensation expense

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Research and development expenses

 

$0.5

 

 

$0.1

 

 

$0.9

 

 

$0.2

 

General and administrative expenses

 

 

1.1

 

 

 

0.3

 

 

 

2.7

 

 

 

1.0

 

Total stock-based compensation expense

 

$1.6

 

 

$0.4

 

 

$3.6

 

 

$1.2